Also found in: Medical, Wikipedia.
CB1Cannabinoid Type 1 (biochemistry)
CB1Circuit Breaker 1 (product code)
CB1Corrected First Born (perturbation theory in atom-ion collisions)
CB1Clinical Building 1 (University of Texas Southwestern Medical Center)
CB1Coxsackie Virus B1 (cardiology research)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
As the cannabinoid-1 receptor (CB1) is found throughout the body's entire central nervous system, Kayser explained that there are high concentrations in regions of the brain that are implicated in OCD.
The pipeline includes CRB-4001, a 2nd generation, selective cannabinoid receptor type 1 (CB1) inverse agonist designed to be peripherally restricted.
Anandamide binds to type 1 cannabinoid receptors (CB1), which are also activated by THC, the main psychoactive cannabinoid in marijuana.
Research studies have shown that the stimulation of CB1 and CB2 receptors can reduce the clinical manifestations of multiple sclerosis, neuropathic and inflammatory pain, and also reduce tumor growth and angiogenesis in some types of cancer.
The principle of the cannabinoid reporter assays is based on the interaction of the cannabinoid receptors, CB1 and CB2, with the cytosolic adapter protein [beta]-arrestin 2 ([beta]arr2).
Based in New York, CB1 Capital Management LLC is an investment adviser that invests in securities of companies in the cannabinoid-wellness space.
Another FAAH inhibitor URB597 delayed the onset and decreased the magnitude of mechanical and heat hyperalgesia and also suppressed established mechanical and thermal hyperalgesia in mice with cisplatin-induced hyperalgesia in a CB1, but not CB2, receptor-dependent manner [25].
Since CBD is attracted to both CB1 and CB2 receptors, it may also serve in a protective capacity.
The conductive fillers (CB1, CB2, and CNT) were premixed in the EAA polymer phase at 9.3 vol% to form a masterbatch prior to compounding the composites where the conductive filler was preferentially distributed in the minor EAA phase.
AEA is responsible for maintaining basal endocannabinoid signalling, binding to both the CB1 and CB2 receptors (13).
Publications from 2000 to 2017 from PubMed/Medline, Scopus were included using the following terms: cannabis, THC, endocannabinoids, cannabinoid receptors, CB1, cannabis mental health, cannabinoid genes, cannabinoids and learning and memory, cannabinoids and mental health.